“…However, evidence from clinical trials suggests that pharmacological services alone or combined with behavioral and psychological support is effective for tobacco/nicotine use and tolerated by smokers with SMI (Aldi, Bertoli, Ferraro, Pezzuto, & Cosci, 2018;Anthenelli et al, 2013;Dubrava & Anthenelli, 2018;Hall et al, 2006;Secades-Villa, González-Roz, García-Pérez, & Becoña, 2017;Tidey & Rohsenow, 2009;Tsoi, Porwal, & Webster, 2013;Williams et al, 2012) Prior evaluations of therapeutic interventions for nicotine dependence in people with SMI recommend pharmacological services to aid smoking cessation (Aldi et al, 2018;Anghelescu, 2009;Annamalai, Singh, & O'Malley, 2015;Cather et al, 2013;Cerimele & Durango, 2012;Evins et al, 2014;Jun, Tian-liang, Bin, & Xianwei, 2009;Rüther et al, 2014;Williams et al, 2012). Recent systematic review and meta-analyses suggest the effectiveness of behavioral services, such as acupressure and acupuncture combined with counseling, in smoking cessation (Wang et al, 2019;Zulkifly & Amin, 2019). These studies also recommend conducting more research to confirm the effectiveness of behavioral services.…”